Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction In Acute-On-Chronic Liver Failure.
Status:
Completed
Trial end date:
2017-01-31
Target enrollment:
Participant gender:
Summary
All consecutive patients admitted in ILBS from MAY 2015 to DECEMBER 2016.ACLF (Acute on
chronic Liver Failure). ACLF will be randomize into
Group 1: MVP (Modest Volume Paracentesis) OF Less than 5 liters with IV albumin at a dose 8
gms/L of ascitic fluid
Group 2: MVP (Modest Volume Paracentesis) of Less than 5 liters without albumin